practolol has been researched along with Cardiovascular Diseases in 9 studies
Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixteen patients with practolol peritonitis are described." | 7.65 | Practolol peritonitis. A study of 16 cases and a survey of small bowel function in patients taking beta adrenergic blockers. ( Baddeley, H; Barritt, DW; Davies, JD; Lee, RE; Low-Beer, TS; Marshall, AJ; Read, AE, 1977) |
| "Betaxolol (Kerlon, 8) was found to exhibit an appropriate preclinical pharmacological and human pharmacokinetic profile (elevated oral bioavailability and prolonged plasma half-life) for the treatment of chronic cardiovascular diseases such as hypertension and angina." | 5.27 | Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases. ( Binet, JL; Cavero, IG; Lefèvre-Borg, F; Manoury, PM; Rousseau, J, 1987) |
| "Sixteen patients with practolol peritonitis are described." | 3.65 | Practolol peritonitis. A study of 16 cases and a survey of small bowel function in patients taking beta adrenergic blockers. ( Baddeley, H; Barritt, DW; Davies, JD; Lee, RE; Low-Beer, TS; Marshall, AJ; Read, AE, 1977) |
| "Arrhythmias were also less frequent through the statistical significance could not be ascertained in this small series." | 2.64 | Circulatory responses to laryngoscopy and endotracheal intubation in patients with and without cardiovascular disease. Effect of prophylactic practolol. ( Hollmén, A; Ryhänen, P; Saarela, E; Saukkonen, J, 1977) |
| "Betaxolol (Kerlon, 8) was found to exhibit an appropriate preclinical pharmacological and human pharmacokinetic profile (elevated oral bioavailability and prolonged plasma half-life) for the treatment of chronic cardiovascular diseases such as hypertension and angina." | 1.27 | Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases. ( Binet, JL; Cavero, IG; Lefèvre-Borg, F; Manoury, PM; Rousseau, J, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Manoury, PM | 1 |
| Binet, JL | 1 |
| Rousseau, J | 1 |
| Lefèvre-Borg, F | 1 |
| Cavero, IG | 1 |
| Huang, KY | 1 |
| Tseng, PT | 1 |
| Wu, YC | 1 |
| Tu, YK | 1 |
| Stubbs, B | 1 |
| Su, KP | 1 |
| Matsuoka, YJ | 1 |
| Hsu, CW | 1 |
| Lin, CH | 1 |
| Chen, YW | 1 |
| Lin, PY | 1 |
| Luyckx, A | 1 |
| Van Cauwenberge, H | 1 |
| Pfeifer, HJ | 1 |
| Greenblatt, DJ | 1 |
| Koch-Weser, J | 1 |
| Ryhänen, P | 1 |
| Saarela, E | 1 |
| Saukkonen, J | 1 |
| Hollmén, A | 1 |
| Marshall, AJ | 1 |
| Baddeley, H | 1 |
| Barritt, DW | 1 |
| Davies, JD | 1 |
| Lee, RE | 1 |
| Low-Beer, TS | 1 |
| Read, AE | 1 |
| Montes Montes, J | 1 |
| Solano, MO | 1 |
| Furberg, CD | 1 |
| Klaus, D | 1 |
2 reviews available for practolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Cardiovascular Diseases; Ce | 2021 |
Beta-adrenergic receptor blocking drugs in hypertrophic cardiomyopathy, autonomically mediated cardiovascular functional disorders and Fallot's tetralogy.
Topics: Adrenergic beta-Antagonists; Alprenolol; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Drug | 1974 |
1 trial available for practolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Circulatory responses to laryngoscopy and endotracheal intubation in patients with and without cardiovascular disease. Effect of prophylactic practolol.
Topics: Adult; Aged; Anesthesia; Arrhythmias, Cardiac; Blood Pressure; Cardiovascular Diseases; Female; Hemo | 1977 |
6 other studies available for practolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Antihypertensive Agents; Betaxolol; Biotra | 1987 |
[Therapeutic news of 1975].
Topics: Bismuth; Cardiovascular Diseases; Diazepam; Drug Therapy; Endocrine System Diseases; Gastrointestina | 1976 |
Adverse reactions to practolol in hospitalized patients: a report from the Boston Collaborative Drug Surveillance Program.
Topics: Aged; Cardiovascular Diseases; Digitalis Glycosides; Drug Interactions; Female; Humans; Male; Middle | 1977 |
Practolol peritonitis. A study of 16 cases and a survey of small bowel function in patients taking beta adrenergic blockers.
Topics: Aged; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Peritoneum; Peritonitis; Practolol | 1977 |
[Asthma from beta blockers. Clinical case].
Topics: Aged; Asthma; Cardiovascular Diseases; Humans; Practolol; Rhinitis, Allergic, Seasonal | 1975 |
[Diagnosis and therapy of functional cardiovascular syndromes].
Topics: Cardiovascular Diseases; Electrocardiography; Humans; Practolol; Propranolol | 1973 |